申请人:GLAXO GROUP LTD
公开号:WO2011103063A1
公开(公告)日:2011-08-25
The present invention features compounds of formula (I): and salts thereof, pharmaceutical compositions comprising said compounds, and uses of such compounds in treating or preventing viral infections, such as HCV infections, and diseases associated with such infections.